Edwards Lifesciences Executive and Leadership Team

Linda Henderson, the Vice President, Chief of Staff To the Chief Executive Officer at Edwards Lifesciences, coordinates executive priorities and facilitates cross-functional communication. Managing the strategic agenda for the leadership team, the Vice President, Chief of Staff To the Chief Executive Officer ensures that organizational goals remain focused on advancing structural heart disease solutions. This position requires constant interaction with senior management to streamline decision-making processes and enhance operational efficiency. By aligning internal resources with the mission of improving patient outcomes, Linda Henderson drives the execution of corporate initiatives. The Vice President, Chief of Staff To the Chief Executive Officer monitors progress on key clinical research projects and maintains the focus of the organization on high-impact medical technology. Through effective management of executive workflows, the Vice President, Chief of Staff To the Chief Executive Officer supports the overall strategic direction of the firm.

Hassan Gawuna, the Deputy Chief Financial Officer at Edwards Lifesciences, manages complex fiscal reporting and capital allocation strategies. Overseeing the financial health of the organization, the Deputy Chief Financial Officer ensures alignment with long-term growth objectives in the medical technology sector. This role involves rigorous analysis of global market trends to support investment in structural heart innovations. By optimizing internal financial controls, Hassan Gawuna directly impacts the ability of the company to fund critical research and development initiatives. The Deputy Chief Financial Officer maintains close coordination with the broader finance team to ensure transparency and regulatory compliance across all international operations. Through precise fiscal planning, the Deputy Chief Financial Officer secures the necessary resources to maintain the market leadership of the firm in cardiovascular care.

Gerianne Sarte, the Senior Vice President, Business Unit Chief Financial Officer - Surgical at Edwards Lifesciences, directs the financial strategy for the surgical structural heart division. Overseeing the budgeting and forecasting for surgical product lines, the Senior Vice President, Business Unit Chief Financial Officer - Surgical ensures that resources support the development of advanced heart valve technologies. This role involves analyzing the profitability of surgical interventions and identifying opportunities for operational improvement. By managing the financial performance of the surgical unit, Gerianne Sarte contributes to the broader success of the company in the global medical device market. The Senior Vice President, Business Unit Chief Financial Officer - Surgical collaborates with clinical and commercial teams to align financial targets with patient care objectives. Through disciplined financial management, the Senior Vice President, Business Unit Chief Financial Officer - Surgical sustains the competitive advantage of the surgical portfolio.

Miyuki Ogushi, the Representative Executive Officer and President and at Edwards Lifesciences, leads regional operations and drives the expansion of medical technology solutions. Overseeing the implementation of corporate strategy within specific markets, the Representative Executive Officer and President and ensures that the mission of the company reaches healthcare professionals effectively. This role involves managing local partnerships and navigating complex regulatory environments to deliver life-changing therapies. By fostering innovation in structural heart care, Miyuki Ogushi strengthens the market position of the firm. The Representative Executive Officer and President and coordinates with global leadership to ensure that regional activities align with the overarching goals of the organization. Through strategic oversight of regional operations, the Representative Executive Officer and President and supports the commitment of the company to improving patient outcomes across diverse healthcare systems.

Geoffrey Crowley, the President at Edwards Lifesciences, directs the overarching business operations and strategic vision for the organization. Overseeing the integration of clinical research and commercial execution, the President ensures that the company remains at the forefront of structural heart disease innovation. This leadership role involves guiding the executive team toward achieving long-term growth and maintaining high standards of patient care. By fostering a culture of excellence, Geoffrey Crowley drives the development of advanced medical technologies that address critical cardiovascular conditions. The President maintains active engagement with the Board and senior leadership to refine the corporate strategy and respond to evolving market needs. Through decisive leadership, the President ensures that the firm continues to deliver life-changing therapies to patients globally, reinforcing the reputation of the company as a leader in medical technology.

Donald Bobo, the Corporate Vice President, Strategy & Corporate Development at Edwards Lifesciences, architects the long-term growth roadmap and identifies strategic acquisition opportunities. Overseeing the evaluation of emerging medical technologies, the Corporate Vice President, Strategy & Corporate Development ensures that the portfolio of the company remains aligned with the needs of patients suffering from structural heart disease. This role involves analyzing market trends and competitive dynamics to inform investment decisions. By managing corporate development initiatives, Donald Bobo expands the reach of the company into new therapeutic areas. The Corporate Vice President, Strategy & Corporate Development collaborates with the executive team to integrate new technologies into the existing product pipeline. Through rigorous strategic planning, the Corporate Vice President, Strategy & Corporate Development secures the future growth and innovation capacity of the firm in the global medical technology landscape.

Joseph Nuzzolese, the Corporate Vice President, Global Supply Chain & Quality at Edwards Lifesciences, manages the end-to-end logistics and manufacturing standards for all medical devices. Overseeing the global supply chain, the Corporate Vice President, Global Supply Chain & Quality ensures that life-changing therapies reach healthcare professionals without interruption. This role involves maintaining strict quality control protocols to meet international regulatory requirements for structural heart products. By optimizing manufacturing processes, Joseph Nuzzolese enhances operational efficiency and reduces costs. The Corporate Vice President, Global Supply Chain & Quality coordinates with regional teams to ensure a resilient supply network capable of meeting global demand. Through the implementation of advanced quality management systems, the Corporate Vice President, Global Supply Chain & Quality guarantees that every product meets the high standards of the company for safety and performance in critical care environments.

Daveen Chopra, the Corporate Vice President, Surgical Structural Heart at Edwards Lifesciences, leads the development and commercialization of surgical heart valve technologies. Overseeing the surgical product portfolio, the Corporate Vice President, Surgical Structural Heart ensures that the company provides surgeons with the most advanced tools for treating complex cardiovascular conditions. This role involves driving clinical research initiatives to validate the efficacy of new surgical interventions. By managing the global launch of surgical products, Daveen Chopra expands the market presence of the firm. The Corporate Vice President, Surgical Structural Heart collaborates with clinical experts to refine product design and improve patient outcomes. Through strategic focus on surgical innovation, the Corporate Vice President, Surgical Structural Heart maintains the leadership of the company in the surgical structural heart market, ensuring that patients receive the highest quality care available.